I consult though Heron Scientific, Inc. mostly in battery technology and markets, for companies leveraging new materials to create a new type of value proposition. This has included to consulting to companies engaged in improving lithium ion, sodium ion, flow battery, and solid state battery chemistries.I help my clients analyze the cost, performance, and competitiveness of their technologies; align their development roadmap to markets and capital; anticipate where alternative solutions will come from and how the competitive landscape will evolve; develop IP strategies; and tell complex technology stories. I have a PhD in chemistry so I understand the technical details (and still love them!). My unique contribution is often putting technology into the appropriate context to analyze or communicate it to non-technical managers, finance professionals, attorneys, or venture investors.I also provide expert services to the legal community. I have been retained nineteen times as an expert, and have testified six times in matters including battery technology, and in chemicals and materials science more broadly. I am comfortable with high stakes litigation, having served as the primary technical expert on a patent case that was resolved as part of a >$1B settlement. I have provided opinions in cases involving patent infringement, trade secret theft, misrepresentations to shareholders, and others. You can see my expert witness resume at sethadrianmiller.com.

We perform cost modeling, performance benchmarking, and forecasting of carbon capture technology, including point source and CDR.

Xinova helps companies find and scale technology growth initiatives that deliver outsized value and returns. I worked on our Map, Design, Build program, performing deep dives into the supply chain of specific industries and analyzing how technology may redirect the flow of cash away from existing players into new pockets. It is a formal process to anticipate disruption, and it works.

Betterpath’s mission is to capture and refine complete sets of health data.From the individual patient seeking care, to the doctor prescribing treatment, to the researcher inventing new ways to treat disease - every stakeholder in the health system suffers from lack of access to complete datasets. By aligning disparate silos of information around each individual, Betterpath seeks to reconcile crucial supplies of health data to facilitate progress toward a better system of medicine.Betterpath’s long-term vision is to become the intermediary entrusted to manage the exchange of value between communities (supply of data) and research (demand for data). To support this vision, Betterpath is deploying our current suite of bespoke software solutions to improve the stakeholder engagement process in clinical research.

Designing a new global platform for sharing IP assets to transform the economics of innovation

President and CEO of Clearmark Systems, an early-stage technology company making a tools for extremely low cost authentication of chips and packages in the semiconductor industry.

Founder and President of the Rocky Mountain section of the Materials Research Society (MRS), a national non-profit scientific organization. As President, I led our executive team to organize talks and provide other services to the local membership.

Fluonic is developing a simple, inexpensive flow senor for the medical infusion marketplace

i2C Solutions is a product development company specializing in high technology solutions requiring a systems-level approach. It has expertise in materials science, mechanical design, electronics, optics, and systems engineering.

I have worked with Ardent both as an inventor and manager in its invention program, helping customers innovate in chemistry and materials science.

Worked as a member of an interdisciplinary team to develop a new type of memory device that relied on the electrochemical addressing of molecules to store data. As part of that team, I invented a new class of gel electrolyte with dramatically improved thermal and materials properties relative to conventional materials. I also designed, built and tested the world's thinnest, fastest electrochemical cells.

I was TI's lead researcher on anti-stiction technologies for the DMD, a micromirror device. These mirrors are capable of making 1 trillion contacts each without any adhesion failures. My innovations in device design, packaging, and process improvements resulted in 11 patents and >$10M in direct revenue improvements and cost savings, and got me elected by my peers to technical staff just 18 months after arriving.

Synthesized and characterized cross-linked liquid crystal materials for use as nanostructured catalysts.